FindTrial
Sign In

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-005902-30-ES
Enrollment
Unknown
Registered
2012-01-27
Start date
2012-02-13
Completion date
Unknown
Last updated
2012-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.1 Level: PT Classification code 10040047 Term: Sepsis System Organ Class: 10021881 - Infections and infestations MedDRA version: 14.1 Level: PT Classification code 10053840 Term: Bacterial sepsis System Organ Class: 10021881 - Infections and infestations

Interventions

Trade Name: Meropenem Kabi 1 g polvo para solución inyectable y para perfusión Pharmaceutical Form: Powder for concentrate for solution for injection/infusion INN or Proposed INN: MEROPENEM CAS Number

Sponsors

Servicio de Farmacia. Hospital Universitari de Bellvitge
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 10 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Spain

Contacts

Public ContactRoser Juvany Roig

Servicio de Farmacia. Hospital Universitari de Bellvitge

rjuvany@bellvitgehospital.cat34932607504

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 21, 2026